10% OFF Crypto | 3rd Party Tested | FREE Worldwide Shipping $400+ ($750+ for USA)
Menu
Cart
Semax 10 mg peptide lyophilized vial
edge peptides semax 10 mg janoshik test
lyophilized peptide vial box (white cap)

Semax 10mg – 10 Vial Box (100mg Total)

$180.0

Cost per vial $: 18

Buy semax peptide 10 mg (one 10-vial box). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Bulk discounts
Quantity Bulk Discount Price
210%$162.0
3-515%$153.0
6-1020%$144.0
SKU: SEM10 Category:

Description

Semax is a synthetic derivative of adrenocorticotropic hormone (ACTH). It’s primarily researched for its nootropic and cognitive benefits, which may stem from semax increasing brain-derived neurotrophic factor (BDNF) levels. Studies also indicate potential effects on immune function, neuron protection, and cardiovascular support. Semax was developed in Russia in the 1990s and is used as a prescription medicine for stroke and cognitive/mental disorders.

Minimum order quantity: one box (10 vials x 10 mg).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

 

 

Additional information

Purity

≥99.0%
Molar Mass

855 g/mol
Molecular Formula

C₃₇H₅₁N₉O₁₀S
Sequence

Met-Glu-His-Phe-Pro-Gly-Pro
Cost per vial $

18
  1. Koroleva, S. V., and N. F. Myasoedov. "Semax as a universal drug for therapy and research." Biology Bulletin 45 (2018): 589-600.
  2. Dolotov, Oleg V., et al. "Semax, an analog of ACTH (4–10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus." Brain research 1117.1 (2006): 54-60.
  3. Eremin, K. O., et al. "Effects of Semax on dopaminergic and serotoninergic systems of the brain." Doklady Biological Sciences. Vol. 394. Kluwer Academic Publishers-Plenum Publishers, 2004.
  4. Dmitrieva, Veronika G., et al. "Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia." Cellular and molecular neurobiology 30 (2010): 71-79.
  5. Samotrueva, M. A., et al. "Experimental substantiation of application of Semax as a modulator of immune reaction on the model of “social” stress." Bulletin of Experimental Biology and Medicine 166.6 (2019): 754-758.
  6. Eremin, Kirill O., et al. "Semax, an ACTH (4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents." Neurochemical Research 30 (2005): 1493-1500.

Semax CoA (2025)

Semax Janoshik Test (July 2025)

Related products